📑NHS Framework for the Midlands and East, Branded Medicines - Tranche B plus Cytokine Modulators and other Monoclonal Antibodies
Procurement process summary
This process is to purchase NHS Framework for the Midlands and East, Branded Medicines - Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.
This contract was awarded by 🇬🇧 The NHS Commissioning Board (operating under the name of NHS England) for an amount of GBP 643,563,034 to 1 supplier. It was published on 2020-10-06 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇬🇧 The NHS Commissioning Board (operating under the name of NHS England) Buying unitnot reported Publication date2020-10-06 Contest statusnot reported DescriptionCM/PHR/20/5591/01 -- Midlands and East, Branded Medicines - Tranche B.Period of framework: 1 March 2021 to 28 February 2023 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5591/02 -- Midlands and East Branded Medicines - Annual Tranche, Cytokine Modulators, other monoclonal antibodies Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma.Period of framework: 1 March 2021 to 28 February 2022 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/20/5591/03 - Supply of Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma to Pan London.Period of framework: 1 March 2021 to 31 August 2021 CM/PHR/20/5591/04 - Supply of Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma to South of England.Period of framework: 1 March 2021 to 31 August 2021.Awards
This award was granted to Janssen-Cilag Ltd by The NHS Commissioning Board (operating under the name of NHS England) for an amount of GBP 643,563,034. The procurement process was conducted through open for the category of goods. This is award number 19.
This contract has multiple awards. This is award number 19. View other awards for this contract
| Supplier | Amount | Award number |
|---|---|---|
| 🇬🇧 Janssen-Cilag Ltd | GBP 643,563,034 | 19 |
Market context and opportunities
The execution of this contract allows the entity The NHS Commissioning Board (operating under the name of NHS England) to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberUK_ocds-70d2nz-185fede2-d8fe-42e9-b03f-4174e2710b1e-award-19Publication date2020-10-06Contract datenot reportedAward datenot reportedCategoriesgoodsPurchase modalityopenMethod detailspt_openStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
